Skip to main content

The figures include expenditure relating to dispensing by GP practices. They do not include the costs of drugs dispensed by high street pharmacies.

View previous publications.

Summary of reported investment from 2016 to 2021

Table 2a: Summary of reported investment from 2016 to 2021
          £ thousands
  2016/2017 2017/2018 2018/2019 2019/2020 2020/2021
Global sum/MPIG 262,886 274,362 295,599 300,022 308,864
Quality 42,338            42,334   42,337 50,224  47,631
           
Direct enhanced services (GMS) 21,441 24,756 32,300 31,305 30,126
National enhanced services (GMS)  7,878 9,549 5,288 6,732 3,333
Local enhanced services 13,452 14,399 13,265 14,836 23,069
Total enhanced services 42,771             48,704  50,853   52,874  56,528
           
Premises 48,317 40,777 42,384  42,440 42,218
PCO administered funds 15,768 18,548 20,112 23,336 26,578
Out of hours (incl. OOH Development Fund 35,592 36,140 37,537 38,705 40,323
IT (including centrally funded IM and T) 13,548 13,900 16,899 14,987 14,000
Total other payments 113,225 109,365 116,932 119,468 123,119
Subtotal 461,220 474,765 505,721 522,588 536,142
           

Country specific investment

         
National primary care fund: direct practice payments   5,434 5,796 5,155 4,858
National primary care fund: Investment on behalf of GP practices   14,266 20,685 22,014 22,412
Total country specific investment   19,700 26,481 27,169 27,270
           
Total net of dispensing 461,220 494,465 532,202 549,757 563,412
           

Cost of dispensing fees (including DSQS) (1)

12,288                       11,894 12,785 12,024 14,289
Total investment excluding reimbursement of drugs (2) 473,508 506,359 544,987 561,781 577,701
Reimbursement of dispensed drugs (incl. vat allowance and discounts) 37,767 37,500 38,307 40,196 39,461
Total spend (3) 511,275 543,859 583,294 601,977 617,162

In 2020/21 there was an increase in the total investment in GP practices of £15.1 million compared to the published 2019/20 figures. 

  1. For items dispensed and/or personally administered by dispensing doctors and prescribing doctor practices.       
  2. Total investment excluding reimbursement of drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.    
  3. For 2017 to 18 and 2018 to 19 includes costs for one APMS contract. 

Note:

  • Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.   
  • National primary care fund expenditure: prior to 2017-18, was only added as a footnote.

Reported investment in general practice 2020 to 2021

Table 2b: Reported Investment in general practice 2020 to 2021
  £ thousands
  Outturn
Global sum 304,906
MPIG correction factor 3,958
Total global sum and MPIG 308,864
   
Quality aspiration payments 9,927
Quality achievement payments 5,164
Quality assurance improvement framework (QAIF) 23,828
QAIF (In hours Access) 8,712
Total quality  47,631
   
Direct enhanced services 30,126
National enhanced services 3,333
Local enhanced services 23,069
Total enhanced services 56,528
   
Premises 42,218
PCO administered funds 26,578
Out of hours 40,323
IM and T 14,000
Total other payments 123,119
Subtotal 536,142

Country specific investment

 
National primary care fund: direct practice payments 4,858
National primary care fund: Investment on behalf of GP practices 22,412
Total country specific investment 27,270
   
Total net of dispensing 563,412
   
Dispensary Services Quality Scheme (DSQS) 493
Cost of dispensing fees (including DSQS) (1) 13,796

Total of all dispensing fees

14,289
   
Total investment excluding reimbursement of drugs (2) 577,701
Reimbursement of dispensed drugs (incl. vat allowance and discounts) 39,461
Total spend 617,162
  1. For items dispensed and/or personally administered by dispensing doctors and prescribing doctor practices.   
  2. Total Investment excluding reimbursement of drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.   

Note: 

  • Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.    
  • National primary care fund expenditure: prior to 2017-18, was only added as a footnote.

Supplementary information 2020 to 2021

Table 2c: Supplementary information 2019 to 2020
  £ thousands
  Outturn

Direct enhanced services

 
Asylum seekers and refugees 2
Care of diabetes 1,045 
Care homes 3,561 
Childhood vaccination and immunisation scheme 6,044
Extended opening times 694
Homeless

56

Influenza and pneumococcal immunisations scheme 11,249
Learning disabilities 294
Mental health 58
Minor surgery fees 2,348
Services for violent patients 168 
Oral anticoagulation with Warfarin 4,586
Gender identity 21
Total direct enhanced services 30,126

PCO administered funds

 
Seniority 5,502
Doctors retainer scheme payments 421
Locum allowances consisting of:  
a) Adoptive, paternity and maternity 2,804
b) Sickness 1,557
c) Suspended doctors 326
d) Other locum payments 52

Appraiser costs

 
Recruitment and retention (incl. golden hello) 23
Primary care development scheme 1,784
Partnership premium 4,303
Designated area allowance  
Initial practice allowance  
Assistant's allowance  
Associate allowance  
Supply of syringes and needles  
Pneumococcal (campaign and catch up)
 
 
Other  9,806
Total PCO administered funds 26,578

Other payments 

 
GP support costs 451
Managed practice costs - managed practices 8,546
Managed practice costs - managing practices  
Primary care initiatives  
GP practice training 67

Translation service costs 

 
Other approved PCO administered costs  742
Total other payments 9,806

Note:

  • Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.
Download this page as a PDF . File size 112 KB.

File size 112 KB. This file may not be fully accessible.